Advertisement

Peritoneal Carcinomatosis and Other Emergencies Not Related to Primary Colorectal Cancer

  • Niccolò Petrucciani
  • Alexis Laurent
  • Francesco Brunetti
  • Nicola de’Angelis
Chapter
Part of the Hot Topics in Acute Care Surgery and Trauma book series (HTACST)

Abstract

Synchronous peritoneal carcinomatosis occurs in approximately 5% of patients with colorectal cancer, whereas metachronous carcinomatosis is reported in 5–19% of cases. It requires medical and, in selected cases, surgical management that most of the times occurs in an emergency setting. Malignant bowel obstruction is a frequent complication of peritoneal carcinomatosis, with potentially severe complications and the need of a complex multidisciplinary management, ranging from medical therapy to interventional endoscopic or radiological procedures to emergency surgery. Careful evaluation of patients’ status, cancer disease history, and expected prognosis is required, if possible by a multidisciplinary team, to establish the optimal treatment. In this chapter, disease presentation, diagnosis, and treatment strategies for peritoneal carcinomatosis presenting in emergency setting are discussed in the light of the recent literature. Furthermore, colitis that may be associated with colorectal cancer or with chemotherapy regimens is discussed, including ischemic, neutropenic, and pseudomembranous colitis. Differential diagnosis of colitis is crucial to establish a prompt and appropriate treatment in these patients. The possibility of incidental diagnosis of colorectal cancer in patients treated for other emergency conditions is also discussed.

Keywords

Colorectal cancer Peritoneal carcinomatosis Malignant bowel occlusion Colic perforation, Emergency surgery 

References

  1. 1.
    Lemoine L, Sugarbaker P, Van der Speeten K. Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum. World J Gastroenterol. 2016;22:7692–707.CrossRefGoogle Scholar
  2. 2.
    Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243:212–22.CrossRefGoogle Scholar
  3. 3.
    Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128:2717–25.CrossRefGoogle Scholar
  4. 4.
    Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99:699–705.CrossRefGoogle Scholar
  5. 5.
    Klaver CE, Groenen H, Morton DG, Laurberg S, Bemelman WA, Tanis PJ. Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines. Colorectal Dis. 2017;19:224–36.CrossRefGoogle Scholar
  6. 6.
    Sadahiro S, Suzuki T, Maeda Y, Tanaka A, Makuuchi H, Kamijo A, Haruki Y, Murayama C. Prognostic factors in patients with synchronous peritoneal carcinomatosis (PC) caused by a primary cancer of the colon. J Gastrointest Surg. 2009;13:1593–8.CrossRefGoogle Scholar
  7. 7.
    Segelman J, Akre O, Gustafsson UO, Bottai M, Martling A. External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer. Colorectal Dis. 2016;18:378–85.CrossRefGoogle Scholar
  8. 8.
    Sugarbaker PH. Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy. Tech Coloproctol. 2005;9:95–103.CrossRefGoogle Scholar
  9. 9.
    Faron M, Macovei R, Goéré D, Honoré C, Benhaim L, Elias D. Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol. 2016;23:114–9.CrossRefGoogle Scholar
  10. 10.
    Goéré D, Malka D, Tzanis D, et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013;257:1065–71.CrossRefGoogle Scholar
  11. 11.
    Elias D, Mariani A, Cloutier AS, et al. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol. 2014;40:1467–73.CrossRefGoogle Scholar
  12. 12.
    Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284–92.CrossRefGoogle Scholar
  13. 13.
    Mo S, Cai G. Multidisciplinary treatment for colorectal peritoneal metastases: review of the literature. Gastroenterol Res Pract. 2016;2016:1516259.CrossRefGoogle Scholar
  14. 14.
    Wu W, Yan S, Liao X, et al. Curative versus palliative treatments for colorectal cancer with peritoneal carcinomatosis: a systematic review and meta-analysis. Oncotarget. 2017;8:113202–12.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Arjona-Sánchez A, Barrios P, Boldo-Roda E, et al. HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma. BMC Cancer. 2018;18:183.CrossRefGoogle Scholar
  16. 16.
    Avital I, Brücher BL, Nissan A, Stojadinovic A. Randomized clinical trials for colorectal cancer peritoneal surface malignancy. Surg Oncol Clin N Am. 2012;21:665–88.CrossRefGoogle Scholar
  17. 17.
    NCCN. Clinical Practice Guidelines in Oncology, Colon Cancer, version 2.18, March 2018. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed April 25, 2018.
  18. 18.
    Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358–63.CrossRefGoogle Scholar
  19. 19.
    Klaver YL, Leenders BJ, Creemers GJ, et al. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin. Am J Clin Oncol. 2013;36:157–61.CrossRefGoogle Scholar
  20. 20.
    Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426–32.CrossRefGoogle Scholar
  21. 21.
    Arakawa K, Kawai K, Ishihara S, et al. Prognostic significance of peritoneal metastasis in stage IV colorectal cancer patients with R0 resection: a multicenter, retrospective study. Dis Colon Rectum. 2017;60:1041–9.CrossRefGoogle Scholar
  22. 22.
    Quere P, Facy O, Manfredi S, Jooste V, Faivre J, Lepage C, Bouvier AM. Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study. Dis Colon Rectum. 2015;58:743–52.CrossRefGoogle Scholar
  23. 23.
    Laval G, Marcelin-Benazech B, Guirimand F, et al. Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manage. 2014;48:75–91.CrossRefGoogle Scholar
  24. 24.
    Silva AC, Pimenta M, Guimarães LS. Small bowel obstruction: what to look for. Radiographics. 2009;29:423–39.CrossRefGoogle Scholar
  25. 25.
    Woolfson RG, Jennings K, Whalen GF. Management of bowel obstruction in patients with abdominal cancer. Arch Surg. 1997;132:1093–7.CrossRefGoogle Scholar
  26. 26.
    Legendre H, Vanhuyse F, Caroli-Bosc FX, Pector JC. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol. 2001;27:364–7.CrossRefGoogle Scholar
  27. 27.
    Dalal KM, Gollub MJ, Miner TJ, et al. Management of patients with malignant bowel obstruction and stage IV colorectal cancer. J Palliat Med. 2011;14:822–8.CrossRefGoogle Scholar
  28. 28.
    Clark K, Lam L, Currow D. Reducing gastric secretions--a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction? Support Care Cancer. 2009;17:1463–8.CrossRefGoogle Scholar
  29. 29.
    Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008;44:1105–15.CrossRefGoogle Scholar
  30. 30.
    Murray-Brown F, Dorman S. Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst Rev. 2015;11(2):CD006271.Google Scholar
  31. 31.
    Obita GP, Boland EG, Currow DC, Johnson MJ, Boland JW. Somatostatin analogues compared with placebo and other pharmacologic agents in the management of symptoms of inoperable malignant bowel obstruction: a systematic review. J Pain Symptom Manage. 2016;52:901–919.e1.CrossRefGoogle Scholar
  32. 32.
    Caceres A, Zhou Q, Iasonos A, Gerdes H, Chi DS, Barakat RR. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series. Gynecol Oncol. 2008;108:482–5.CrossRefGoogle Scholar
  33. 33.
    Mendelsohn RB, Gerdes H, Markowitz AJ, DiMaio CJ, Schattner MA. Carcinomatosis is not a contraindication to enteral stenting in selected patients with malignant gastric outlet obstruction. Gastrointest Endosc. 2011;73:1135–40.CrossRefGoogle Scholar
  34. 34.
    Brooksbank MA, Game PA, Ashby MA. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med. 2002;16:520–6.CrossRefGoogle Scholar
  35. 35.
    Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML. Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surg. 2014;149:383–92.CrossRefGoogle Scholar
  36. 36.
    Shariat-Madar B, Jayakrishnan TT, Gamblin TC, Turaga KK. Surgical management of bowel obstruction in patients with peritoneal carcinomatosis. J Surg Oncol. 2014;110:666–9.CrossRefGoogle Scholar
  37. 37.
    Ko GY, Ha HK, Lee HJ, et al. Usefulness of CT in patients with ischemic colitis proximal to colonic cancer. AJR Am J Roentgenol. 1997;168:951–6.CrossRefGoogle Scholar
  38. 38.
    Xiong L, Chintapalli KN, Dodd GD, et al. Frequency and CT patterns of bowel wall thickening proximal to cancer of the colon. AJR Am J Roentgenol. 2004;182:905–9.CrossRefGoogle Scholar
  39. 39.
    Jang HJ, Lim HK, Park CK, Kim SH, Park JM, Choi YL. Segmental wall thickening in the colonic loop distal to colonic carcinoma at CT: importance and histopathologic correlation. Radiology. 2000;216:712–7.CrossRefGoogle Scholar
  40. 40.
    Chiu HH, Chen CM, Mo LR, Chao TJ. Gastrointestinal: ischemic colitis associated with colon cancer. J Gastroenterol Hepatol. 2005;20:1458.CrossRefGoogle Scholar
  41. 41.
    Rodrigues FG, Dasilva G, Wexner SD. Neutropenic enterocolitis. World J Gastroenterol. 2017;23:42–7.CrossRefGoogle Scholar
  42. 42.
    Gorschlüter M, Mey U, Strehl J, et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol. 2005;75:1–13.CrossRefGoogle Scholar
  43. 43.
    Ong GK, Reidy TJ, Huk MD, Lane FR. Clostridium difficile colitis: a clinical review. Am J Surg. 2017;213:565–71.CrossRefGoogle Scholar
  44. 44.
    Morales Chamorro R, Serrano Blanch R, Méndez Vidal MJ, Gómez España MA, Rubio Pérez MJ, de la Haba Rodríguez JR, Aranda Aguilar E. Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil. Clin Transl Oncol. 2005;7:258–61.CrossRefGoogle Scholar
  45. 45.
    GLOBOCAN 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed April 25, 2018.
  46. 46.
    Mangat S, Kozoriz MG, Bicknell S, Spielmann A. The accuracy of colorectal cancer detection by computed tomography in the unprepared large bowel in a community-based hospital. Can Assoc Radiol J. 2018;69:92–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Niccolò Petrucciani
    • 1
    • 2
  • Alexis Laurent
    • 1
    • 2
  • Francesco Brunetti
    • 1
    • 2
  • Nicola de’Angelis
    • 1
    • 2
  1. 1.Unit of Digestive, Hepato-Pancreato-Biliary Surgery and Liver TransplantationHenri Mondor Hospital, AP-HPCréteilFrance
  2. 2.University of Paris Est, UPECCréteilFrance

Personalised recommendations